Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.antiviral.2010.02.315
Title: Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice
Authors: Prabakaran, M.
Madhan, S.
Prabhu, N.
Kwang, J. 
Geng, G.Y.
New, R.
Keywords: Baculovirus
H5N1
Oral
Reverse micelle
Surface display
Issue Date: 2010
Source: Prabakaran, M., Madhan, S., Prabhu, N., Kwang, J., Geng, G.Y., New, R. (2010). Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Antiviral Research 86 (2) : 180-187. ScholarBank@NUS Repository. https://doi.org/10.1016/j.antiviral.2010.02.315
Abstract: Induction of mucosal immunity through oral immunization is an effective way to control influenza infection. In this study, baculovirus displaying influenza hemagglutinin was encapsulated within a reverse micelle structure of phosphatidylcholine and delivered into the gastrointestinal tract of mice to study its efficacy as an oral vaccine against cross-clade H5N1 infection. Mice vaccinated with encapsulated baculovirus displaying HA (En-BacHA) showed significantly enhanced HA specific serum IgG and mucosal IgA antibodies, and higher hemagglutination inhibition (HI) titers, when compared to its non-encapsulated form (BacHA). Estimation of serum neutralizing antibodies also indicated that En-BacHA formulation was able to induce strong cross-clade neutralization against heterologous H5N1 strains (clade 1.0, clade 2.1, clade 4.0 and clade 8.0). Further, mice vaccinated with En-BacHA alone were able to confer 100% protection against 5. MLD50 of HPAI heterologous H5N1 strain (clade 1). Inclusion of recombinant cholera toxin B subunit as a mucosal adjuvant in the vaccine formulation did not show any significant effect in both systemic and mucosal immune responses. Oral delivery of encapsulated recombinant H5 HA expressed on baculovirus surface is an effective way to prime the immune system against H5N1 infection in mice and will have no biosafety concerns associated with their production or administration. © 2010 Elsevier B.V.
Source Title: Antiviral Research
URI: http://scholarbank.nus.edu.sg/handle/10635/24744
ISSN: 01663542
18729096
DOI: 10.1016/j.antiviral.2010.02.315
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

19
checked on Jan 17, 2018

WEB OF SCIENCETM
Citations

18
checked on Jan 17, 2018

Page view(s)

221
checked on Jan 23, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.